JFL Life Sciences will hold an EGM on October 28, 2025, to boost its authorized share capital from Rs 50 Cr to Rs 67.50 Cr.

This is a crucial step to facilitate a future Rights Issue, aiming to raise funds for expansion and operational working capital.

Only shareholders on record by September 26, 2025, can vote on this strategic capital move.

The Board views this increase as essential for the company's growth plans.